EMPIRE STATE REALTY TRUST-A (ESRT) Stock Fundamental Analysis
NYSE:ESRT - US2921041065 - REIT
7.88 USD
+0.2 (+2.6%)
Taking everything into account, ESRT scores 4 out of 10 in our fundamental rating. ESRT was compared to 129 industry peers in the Diversified REITs industry. ESRT has an average financial health and profitability rating. ESRT is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year ESRT was profitable.
ESRT had a positive operating cash flow in the past year.
In multiple years ESRT reported negative net income over the last 5 years.
ESRT had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of 0.99%, ESRT perfoms like the industry average, outperforming 54.26% of the companies in the same industry.
ESRT has a better Return On Equity (3.79%) than 60.47% of its industry peers.
The Return On Invested Capital of ESRT (3.01%) is comparable to the rest of the industry.
ESRT had an Average Return On Invested Capital over the past 3 years of 2.75%. This is in line with the industry average of 3.04%.
The 3 year average ROIC (2.75%) for ESRT is below the current ROIC(3.01%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.99% | ||
| ROE | 3.79% | ||
| ROIC | 3.01% |
ROA(3y)1.03%
ROA(5y)0.49%
ROE(3y)4.33%
ROE(5y)2.08%
ROIC(3y)2.75%
ROIC(5y)2.24%
1.3 Margins
ESRT's Profit Margin of 5.26% is in line compared to the rest of the industry. ESRT outperforms 51.94% of its industry peers.
ESRT's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 19.41%, ESRT perfoms like the industry average, outperforming 45.74% of the companies in the same industry.
In the last couple of years the Operating Margin of ESRT has remained more or less at the same level.
The Gross Margin of ESRT (54.42%) is worse than 74.42% of its industry peers.
ESRT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.41% | ||
| PM (TTM) | 5.26% | ||
| GM | 54.42% |
OM growth 3Y14.11%
OM growth 5Y-0.46%
PM growth 3YN/A
PM growth 5Y-1.77%
GM growth 3Y-0.96%
GM growth 5Y-0.19%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ESRT is destroying value.
Compared to 1 year ago, ESRT has more shares outstanding
The number of shares outstanding for ESRT has been reduced compared to 5 years ago.
The debt/assets ratio for ESRT is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 0.61, we must say that ESRT is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.61, ESRT perfoms like the industry average, outperforming 57.36% of the companies in the same industry.
ESRT has a Debt/Equity ratio of 1.93. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.93, ESRT is doing worse than 68.99% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.93 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.61 |
ROIC/WACC0.48
WACC6.28%
2.3 Liquidity
A Current Ratio of 2.37 indicates that ESRT has no problem at all paying its short term obligations.
The Current ratio of ESRT (2.37) is better than 86.05% of its industry peers.
A Quick Ratio of 2.37 indicates that ESRT has no problem at all paying its short term obligations.
The Quick ratio of ESRT (2.37) is better than 86.05% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.37 | ||
| Quick Ratio | 2.37 |
3. Growth
3.1 Past
ESRT shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -9.88%.
Measured over the past years, ESRT shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.83% on average per year.
ESRT shows a small growth in Revenue. In the last year, the Revenue has grown by 1.78%.
The Revenue has been growing slightly by 0.98% on average over the past years.
EPS 1Y (TTM)-9.88%
EPS 3YN/A
EPS 5Y-8.83%
EPS Q2Q%120%
Revenue 1Y (TTM)1.78%
Revenue growth 3Y7.16%
Revenue growth 5Y0.98%
Sales Q2Q%-18.99%
3.2 Future
Based on estimates for the next years, ESRT will show a very negative growth in Earnings Per Share. The EPS will decrease by -37.27% on average per year.
Based on estimates for the next years, ESRT will show a small growth in Revenue. The Revenue will grow by 1.75% on average per year.
EPS Next Y-85.43%
EPS Next 2Y-64.01%
EPS Next 3Y-51.61%
EPS Next 5Y-37.27%
Revenue Next Year1.8%
Revenue Next 2Y2.37%
Revenue Next 3Y2.12%
Revenue Next 5Y1.75%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
ESRT is valuated reasonably with a Price/Earnings ratio of 10.79.
95.35% of the companies in the same industry are more expensive than ESRT, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of ESRT to the average of the S&P500 Index (27.03), we can say ESRT is valued rather cheaply.
A Price/Forward Earnings ratio of 96.57 indicates a quite expensive valuation of ESRT.
ESRT's Price/Forward Earnings is on the same level as the industry average.
ESRT is valuated expensively when we compare the Price/Forward Earnings ratio to 22.54, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.79 | ||
| Fwd PE | 96.57 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ESRT is valued cheaper than 88.37% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 9.69 |
4.3 Compensation for Growth
A cheap valuation may be justified as ESRT's earnings are expected to decrease with -51.61% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-64.01%
EPS Next 3Y-51.61%
5. Dividend
5.1 Amount
ESRT has a Yearly Dividend Yield of 1.78%.
Compared to an average industry Dividend Yield of 6.63, ESRT's dividend is way lower than its industry peers. On top of this 88.37% of the companies listed in the same industry pay a better dividend than ESRT!
ESRT's Dividend Yield is slightly below the S&P500 average, which is at 2.45.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.78% |
5.2 History
The dividend of ESRT decreases each year by -17.38%.
ESRT has been paying a dividend for at least 10 years, so it has a reliable track record.
ESRT has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-17.38%
Div Incr Years0
Div Non Decr Years3
5.3 Sustainability
68.41% of the earnings are spent on dividend by ESRT. This is not a sustainable payout ratio.
ESRT's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP68.41%
EPS Next 2Y-64.01%
EPS Next 3Y-51.61%
NYSE:ESRT (9/11/2025, 10:33:17 AM)
7.88
+0.2 (+2.6%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners94.24%
Inst Owner Change5.91%
Ins Owners0.08%
Ins Owner Change-0.14%
Market Cap1.34B
Analysts75
Price Target9.04 (14.72%)
Short Float %2.96%
Short Ratio2.65
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.78% |
Yearly Dividend0.17
Dividend Growth(5Y)-17.38%
DP68.41%
Div Incr Years0
Div Non Decr Years3
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.34%
PT rev (3m)-3.28%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.45%
Revenue NY rev (3m)-0.73%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.79 | ||
| Fwd PE | 96.57 | ||
| P/S | 1.74 | ||
| P/FCF | N/A | ||
| P/OCF | 5.09 | ||
| P/B | 1.25 | ||
| P/tB | 5 | ||
| EV/EBITDA | 9.69 |
EPS(TTM)0.73
EY9.26%
EPS(NY)0.08
Fwd EY1.04%
FCF(TTM)-0.87
FCFYN/A
OCF(TTM)1.55
OCFY19.66%
SpS4.53
BVpS6.3
TBVpS1.58
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.99% | ||
| ROE | 3.79% | ||
| ROCE | 3.81% | ||
| ROIC | 3.01% | ||
| ROICexc | 3.08% | ||
| ROICexgc | 3.9% | ||
| OM | 19.41% | ||
| PM (TTM) | 5.26% | ||
| GM | 54.42% | ||
| FCFM | N/A |
ROA(3y)1.03%
ROA(5y)0.49%
ROE(3y)4.33%
ROE(5y)2.08%
ROIC(3y)2.75%
ROIC(5y)2.24%
ROICexc(3y)2.99%
ROICexc(5y)2.46%
ROICexgc(3y)3.81%
ROICexgc(5y)3.15%
ROCE(3y)3.48%
ROCE(5y)2.83%
ROICexcg growth 3Y18.9%
ROICexcg growth 5Y-2.68%
ROICexc growth 3Y19.87%
ROICexc growth 5Y-1.77%
OM growth 3Y14.11%
OM growth 5Y-0.46%
PM growth 3YN/A
PM growth 5Y-1.77%
GM growth 3Y-0.96%
GM growth 5Y-0.19%
F-Score7
Asset Turnover0.19
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.93 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 6.11 | ||
| Cap/Depr | 218.69% | ||
| Cap/Sales | 53.45% | ||
| Interest Coverage | 1.51 | ||
| Cash Conversion | 77.94% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.37 | ||
| Quick Ratio | 2.37 | ||
| Altman-Z | 0.61 |
F-Score7
WACC6.28%
ROIC/WACC0.48
Cap/Depr(3y)133.09%
Cap/Depr(5y)115.91%
Cap/Sales(3y)34.64%
Cap/Sales(5y)32.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.88%
EPS 3YN/A
EPS 5Y-8.83%
EPS Q2Q%120%
EPS Next Y-85.43%
EPS Next 2Y-64.01%
EPS Next 3Y-51.61%
EPS Next 5Y-37.27%
Revenue 1Y (TTM)1.78%
Revenue growth 3Y7.16%
Revenue growth 5Y0.98%
Sales Q2Q%-18.99%
Revenue Next Year1.8%
Revenue Next 2Y2.37%
Revenue Next 3Y2.12%
Revenue Next 5Y1.75%
EBIT growth 1Y-2.8%
EBIT growth 3Y22.28%
EBIT growth 5Y0.51%
EBIT Next Year131.1%
EBIT Next 3Y34.69%
EBIT Next 5Y20.13%
FCF growth 1Y-427.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y12.55%
OCF growth 3Y7.08%
OCF growth 5Y2.32%